Article Details

FDA approves Biotest's Yimmugo - biopharma-reporter.com

Retrieved on: 2024-06-20 13:00:07

Tags for this article:

Click the tags to see associated articles and topics

FDA approves Biotest's Yimmugo - biopharma-reporter.com. View article details on hiswai:

Excerpt

Biotest, a subsidiary of Grifols, has received FDA approval for Yimmugo, a treatment for primary antibody deficiency syndromes (PID)

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up